Author: Kanika Gupta
Date: 26 Dec 2022
Time: 2:56 pm
The stock price of Bharat Immunologicals & Biologicals Corporation has increased 61% during the last three trading days.
The company is engaged in the manufacturing of oral polio vaccine, zinc tablets, diarehha management kits and BIB sweet tablets.
According to Bharat Immunologicals & Biologicals Corporation's FY22 annual report, the company is actively diversifying.
Additionally, the business has been given permission to increase the nation's manufacturing of the Covid-19 vaccine, commonly known as Covaxin.